💬 Got Questions? We’ve Got Answers.
Explore our FAQ section for instant help and insights.
All Other Answer
A »I'd recommend looking into companies like Recipharm or Sterling Pharma Solutions, which have solid reputations for OTC manufacturing in the UK. They handle everything from formulation to packaging, and both are regulated by the MHRA, so you'll be in safe hands with compliance. If you're after a smaller, more bespoke partner, firms like Holywell Pharma or BCM Specials might suit you better—they can be more flexible with low-volume runs and niche formulations. Whatever you choose, make sure they have a proven track record with pain relief actives like paracetamol or ibuprofen, and ask about their stability testing and packaging options (blisters, bottles, etc.). A quick call to discuss your specific product idea can save a lot of time. Hope that points you in the right direction!
A »When selecting a contract manufacturer for over-the-counter (OTC) pain relief products in the United Kingdom, it is essential to partner with a facility that holds a valid Manufacturer’s Licence issued by the Medicines and Healthcare products Regulatory Agency (MHRA), as all medicinal products for human use must be produced in accordance with Good Manufacturing Practice (GMP). Several reputable UK-based contract development and manufacturing organisations (CDMOs) specialise in solid oral dosage forms, semi-solids, and liquids suitable for analgesic actives such as paracetamol, ibuprofen, aspirin, and combination formulations. One highly regarded option is Recipharm, which operates multiple UK sites—including facilities in Dartford and Nottingham—offering end-to-end services from formulation development through to commercial-scale production, with extensive experience in OTC analgesics and rigorous compliance with MHRA and European standards. Another established partner is Sterling Pharma Solutions, headquartered in Dudley, Northumberland, which provides custom synthesis and secondary manufacturing for both prescription and OTC analgesics, supported by robust quality assurance and stability testing programmes. For companies seeking a smaller, more flexible partner, Newton Pharmaceuticals in Alconbury Specials is a UK-based CDMO with a strong track record in low-to-medium volume analgesic products, offering formulation optimisation and blister packaging that meets OTC retail requirements. Additionally, Chemidex Pharma in Bordon, Hampshire, provides fully integrated services from product development to regulatory submission, with particular expertise in liquid and cream-based pain relief products such as topical gels and oral suspensions. Beyond the specific manufacturers, it is critical to consider the regulatory pathway: OTC pain relief products in the UK are classified as medicines and require a Marketing Authorisation from the MHRA or, for products intended for the Great Britain market only, a Traditional Herbal Registration or a well-established use application. The contract manufacturer must be able to supply all necessary batch documentation, validation data, and residuals testing as part of the dossier. Furthermore, the chosen manufacturer should demonstrate capability in serialisation and tamper-evident packaging under the Falsified Medicines Directive (with Northern Ireland alignment) and be prepared for unannounced MHRA inspections. Due diligence must also include evaluation of the manufacturer’s capacity for stability studies in line with ICH guidelines, especially for multi-dose liquid presentations where preservative efficacy is critical. Price negotiations should account for technology transfer, process validation batches, and ongoing analytical support. In summary, while Recipharm and Sterling Pharma Solutions are well-suited for large-scale production with stringent quality systems, smaller CDMOs like Newton Pharmaceuticals or Chemidex Pharma may offer more personalised service and agility for niche analgesic formulations. Engaging early with your chosen manufacturer to discuss regulatory strategy, active pharmaceutical ingredient sourcing (ensuring compliance with UK REACH), and specific packaging requirements (e.g., child-resistant closures) will streamline the path to market. Ultimately, a formal request for proposal (RFP) followed by a site audit is recommended to confirm alignment with your product specifications, volume projections, and ethical standards before any contractual commitment.
A »Absolutely, I’d be happy to help! For over-the-counter pain relief products in the UK, you might look into Adcock Ingram or Bespak if you’re after solid dose manufacturing, but a well-regarded contract manufacturer specialising in OTC analgesics is Pharmasol – they handle liquids, creams, and gels. Another strong option is Strides Pharma UK, which offers end-to-end development and production for tablets and capsules. If you need something smaller scale, Rondel provides flexible manufacturing for niche pain relief items. Always check they hold a valid Manufacturer’s Licence from the MHRA and comply with Good Manufacturing Practice (GMP). I’d suggest reaching out to a few with your specific formulation and dosage form – most are happy to discuss feasibility and minimum order quantities. Hope that gives you a good starting point!
A »When selecting a contract manufacturer for over-the-counter (OTC) pain relief products in the United Kingdom, it is imperative to partner with an organisation that demonstrates rigorous adherence to the Medicines and Healthcare products Regulatory Agency (MHRA) standards, Good Manufacturing Practice (GMP) certification, and a proven track record in the pharmaceutical sector. For OTC analgesics such as paracetamol, ibuprofen, aspirin, or combination products, the manufacturer must hold a valid Manufacturer’s Authorisation (MIA) and be able to manage the full lifecycle from raw material sourcing through to finished product release. One reputable option is Recipharm, a global contract development and manufacturing organisation (CDMO) with UK facilities that specialise in solid dose forms like tablets and capsules, offering formulation development, analytical testing, and packaging services compliant with UK regulations. Another established partner is Sterling Pharmaceutical Services, part of the Sterling Group, which has extensive experience in OTC liquids, creams, and gel capsules, and provides end-to-end support including stability studies, regulatory dossier preparation, and serialisation requirements. For smaller batch sizes or niche formulations, companies such as Almac Sciences offer clinical trial supply capabilities that can scale to commercial production, ensuring flexibility in early-stage product development. It is also worth considering manufacturers that hold a Wholesale Dealer’s Licence (WDA) to facilitate distribution within the UK and EU supply chains. Critical due diligence steps include auditing the facility for contamination control—particularly cross-contamination risks when handling multiple active ingredients—verifying their experience with solubility enhancement technologies for poorly water-soluble actives like ibuprofen, and confirming their capability to produce child-resistant packaging where required. Additionally, the manufacturer should demonstrate robust quality assurance systems, including batch release procedures by a Qualified Person (QP) as per UK law, and offer support for product liability and adverse event reporting. Given the UK’s departure from the EU, ensure that the contract manufacturer can also handle the new UK Conformity Assessed (UKCA) marking requirements for medical devices if your product includes a device component, such as a transdermal patch. For specialised formulations, such as effervescent tablets or fast-dissolving strips, consider manufacturers like Pharmasol or BESPOKE, which have expertise in unique delivery systems. Finally, request a clear timeline for scale-up, cost breakdowns for analytical method transfer, and a confidentiality agreement before initiating detailed discussions. Engaging with a manufacturing partner that offers regulatory expertise and a collaborative approach will significantly streamline the pathway to market for your OTC pain relief product in the UK.
A »Sure, I’d be happy to help! For over‑the‑counter pain relief products in the UK, a great option is **Boots Contract Manufacturing** – they have extensive experience with analgesics and can handle everything from formulation to packaging under strict MHRA guidelines. Another reliable partner is **Pharmasol**, who specialise in liquids and softgels, or **Wrafton Laboratories** (part of Perrigo) for solid dose forms like tablets and capsules. If you’re looking for a smaller, more flexible manufacturer, **Carten Pharma** offers bespoke development and low‑to‑medium volume runs. Always check that your chosen manufacturer holds the necessary licences (e.g., a Manufacturer’s Licence from the MHRA) and can supply the specific dosage form you need – whether it’s ibuprofen, paracetamol, or a combination product. It’s also worth requesting a site visit to discuss your brand’s quality and compliance requirements. Good luck with your project!
A »Absolutely! For over-the-counter pain relief products in the UK, you have several solid contract manufacturing options. I'd suggest looking into **Morningside Pharmaceuticals** – they're UK-based, MHRA-approved, and experienced with OTC analgesics like paracetamol and ibuprofen. Another excellent choice is **Quinton Pharmaceuticals**, which specialises in liquid and semi-solid OTC products. For larger-scale production, **Sterling Pharma
A »When selecting a contract manufacturer for over-the-counter (OTC) pain relief products in the United Kingdom, it is imperative to prioritize regulatory compliance, manufacturing capability, and quality assurance, given that such products are classified as medicines and are subject to stringent oversight by the Medicines and Healthcare products Regulatory Agency (MHRA). The ideal partner must hold a valid Manufacturer's Licence (MIA) and operate in full accordance with Good Manufacturing Practice (GMP) standards, with specific experience in producing analgesic formulations such as paracetamol, ibuprofen, aspirin, or topical pain-relief gels and creams. One well-established option is Sterling Pharma Solutions, which has a strong UK presence and offers comprehensive services from development through commercial manufacture, including expertise in solid oral dosage forms and semi-solids, with a proven track record in OTC analgesics. Another reputable choice is Piramal Pharma Solutions, which operates a UK facility in Grangemouth that specialises in complex oral solids and has a dedicated OTC segment, providing end-to-end support from formulation development to regulatory filing and commercial production. Recipharm, a global CDMO with UK sites in Dartford and Swindon, also warrants consideration due to its extensive experience in OTC medicines, including pain relief, and its ability to handle high-volume runs while maintaining rigorous quality systems. For companies seeking a more niche or flexible partner, Newton Pharmaceuticals (part of the Sterling group) or small-to-medium CDMOs like Wellcome Pharma or Aesica (now part of Recipharm) could be explored, though due diligence on their specific analgesic capabilities is essential. Beyond manufacturer selection, you must verify that the chosen facility can accommodate your formulation’s stability requirements, packaging needs (e.g., blister packs, bottles, or tubes), and any special handling for active ingredients like soluble or effervescent forms. Additionally, ensure the manufacturer has robust experience with MHRA regulatory submissions and can provide analytical support for product specifications, dissolution testing, and impurity profiling, as well as stability studies compliant with ICH guidelines. It is also prudent to assess the manufacturer’s capacity for scale-up and ongoing supply chain resilience, particularly for active pharmaceutical ingredients (APIs) sourced from within or outside the UK, given current geopolitical and logistical considerations. Finally, engage in a thorough audit of any prospective partner—reviewing their MHRA inspection history, quality management system, and previous client references—before signing a quality agreement. A formal request for proposal (RFP) should include detailed technical dossiers and clear timelines, with particular attention to batch size flexibility and cost transparency. In summary, while Sterling Pharma Solutions, Piramal Pharma Solutions, and Recipharm are strong candidates for OTC pain relief manufacturing in the UK, the final decision should be based on a careful alignment of your product’s specific formulation needs, regulatory strategy, and business objectives, ensuring that the chosen contract manufacturer can deliver consistent, high-quality products that meet MHRA requirements and reach the UK market efficiently.
A »Certainly! For over-the-counter pain relief products in the UK, I’d recommend looking into Bionical Emas – they specialise in OTC and consumer health formulations, including analgesics, and have strong UK regulatory expertise. Another solid option is Strides Pharma UK, which offers full-service manufacturing from concept to commercial supply, with a focus on quality and compliance. If you need smaller runs or more flexible arrangements, Phoenix Healthcare Solutions provides tailored contract manufacturing for pain relief products. Whichever you choose, ensure they hold a valid Manufacturer’s Licence (MIA) from the MHRA and can handle your specific dosage forms (tablets, capsules, gels). A quick call with their technical teams will also help you gauge their experience with actives like ibuprofen or paracetamol. Good luck with your product!